Abstract
Members of the viral family Flaviviridae are a major cause of infectious diseases, such as hepatitis C, Dengue fever, Japanese encephalitis, Yellow fever or West Nile fever. Major efforts are therefore being made to identify medicines that can fight these infections. The genome of the Flaviviridae contains a single ORF that is translated into a precursor polyprotein which is processed in the host into several proteins. Amongst these, the nonstructural protein 3 (NS3) is formed from two domains that show distinct catalytic activities: a serine protease and a helicase activity. Since both activities are required for viral replication, there is a lot of interest in investigating NS3 as a potential drug target. On the basis of the structural information available, we shall assess here the druggability of the helicase domain of NS3.
Keywords: NS3 helicase, hepatitis C virus, dengue virus, west nile virus
Current Chemical Biology
Title: NS3 Helicases as Drug Targets
Volume: 3 Issue: 3
Author(s): Patrick Chene
Affiliation:
Keywords: NS3 helicase, hepatitis C virus, dengue virus, west nile virus
Abstract: Members of the viral family Flaviviridae are a major cause of infectious diseases, such as hepatitis C, Dengue fever, Japanese encephalitis, Yellow fever or West Nile fever. Major efforts are therefore being made to identify medicines that can fight these infections. The genome of the Flaviviridae contains a single ORF that is translated into a precursor polyprotein which is processed in the host into several proteins. Amongst these, the nonstructural protein 3 (NS3) is formed from two domains that show distinct catalytic activities: a serine protease and a helicase activity. Since both activities are required for viral replication, there is a lot of interest in investigating NS3 as a potential drug target. On the basis of the structural information available, we shall assess here the druggability of the helicase domain of NS3.
Export Options
About this article
Cite this article as:
Chene Patrick, NS3 Helicases as Drug Targets, Current Chemical Biology 2009; 3 (3) . https://dx.doi.org/10.2174/2212796810903030334
DOI https://dx.doi.org/10.2174/2212796810903030334 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design Perspectives of Medieval Persian Medicine on Multiple Sclerosis
Current Drug Metabolism Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Baseline Levels of Interleukine-6, Tumor-Necrosis Factor-Alpha and C-Reactive Protein in Treatment Naive Human Immunodeficiency Virus Infected Patients-A Study from a Tertiary-Care Hospital in Eastern India
Current Biomarkers (Discontinued) Inhibition of Flaviviridae Replication Complex: Assays to Investigate the Modulating Effect of Potential Compounds
Current Enzyme Inhibition The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Natural Killer Cells Adjudicate Every Stage of Anti-Viral Immune Response
Current Immunology Reviews (Discontinued) Identification of Uptake Mechanism of Cell-Penetrating Peptides by their Polar Profile
Current Bioinformatics Advances in Reprogramming to Pluripotency
Current Stem Cell Research & Therapy Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) Natural Products as a Paradigm for the Treatment of Coxsackievirus - induced Myocarditis
Current Topics in Medicinal Chemistry Current Concepts on Selected Plant Secondary Metabolites With Promising Inhibitory Effects Against Enzymes Linked to Alzheimer’s Disease
Current Medicinal Chemistry Plant Phenolic Compounds as Potential Lead Compounds in Functional Foods for Antiviral Drug Discovery
Current Organic Chemistry MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Inhibition of MHC II Gene Transcription by Nitric Oxide and Antioxidants
Current Pharmaceutical Design Endothelial Chemokines in Autoimmune Disease
Current Pharmaceutical Design Immune Senescence and Vaccination in the Elderly
Current Topics in Medicinal Chemistry